peak) measurement and anterior segments examination.

4 trials

Sponsors

Hospital, University of the Ryukyus

Conditions

Glaucomaprimary open angle glaucoma and ocular hypertension

Unknown Phase

Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues

Active, not recruitingJPRN-UMIN000006828

Hospital, University of the Ryukyusprimary open angle glaucoma and ocular hypertension

Start: 2011-03-01Target: 40Updated: 2026-06-29

Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues and beta-blocker

Active, not recruitingJPRN-UMIN000006829

Hospital, University of the RyukyusGlaucoma

Start: 2011-03-01Target: 20Updated: 2026-06-29

Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues, beta-blocker and CAI

Active, not recruitingJPRN-UMIN000006831

Hospital, University of the RyukyusGlaucoma

Start: 2011-03-01Target: 20Updated: 2026-06-29

Evaluation of dorzolamide/timolol fixed-dose combination therapy for the patients who need more IOP (trough & peak) reduction under treatment of PG analogues and CAI

Active, not recruitingJPRN-UMIN000006830

Hospital, University of the RyukyusGlaucoma

Start: 2011-03-01Target: 20Updated: 2026-06-29